Download the 2026 Economic Impact Report
Join Now
Join Now

Booster Biosciences: Oncology Startup Chosen For SCbioDrive Accelerator Program

SOUTH CAROLINA – September 17, 2024 – Booster Biosciences, located in Melrose, Massachusetts, leverages novel biological models developed at Harvard Medical School to discover the mechanisms of resistance and engineer optimal therapeutics. Their portfolio of patented therapeutics targets resistance to conventional and immuno-oncology drugs.

Solutions

Cancer therapies are plagued by resistance, which drives mortality. Booster Biosciences is pioneering the fight against drug resistance by leveraging cutting-edge biological models developed at Harvard Medical School. Their company is the first to develop a portfolio of therapeutics that target cancer cell states through drug-induced resistance, addressing the critical challenge of non-mutational mechanisms of resistance. The company’s patented therapeutics are designed to enhance the efficacy of existing FDA-approved cancer therapies that often fail in the clinic. By utilizing a suite of novel complex biological models, Booster Biosciences is redefining drug development, enabling more efficient and effective therapeutic solutions for cancer patients.

Strengths

  1. Cancer Cell Targeting:
    • Booster Biosciences is the first company to develop a portfolio of drugs that target cancer cell states via drug-induced resistance.
  2. Expert Resistance Team:
    • Booster comprises a team of experts in non-mutational mechanisms of drug resistance.
  3. Therapy Enhancement Drugs:
    • Booster has a novel series of drugs that boost the activity of existing FDA-approved cancer therapies that tend to fail in the clinic.
  4. Advanced Drug Models:
    • Booster leverages a suite of novel complex biological models that allow for better, more efficient drug development.

Meet the Co-Founders

From left to right:

Aaron Goldman – Faculty and Instructor in Medicine | Harvard Medical School

Denton Chase – VP Business Development | Focus Medical Communications

Arpita Kulkarni – Associate Director, SCC | Harvard Medical School

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Join Today!

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.